On the other hand, the increased GAD activity and expression (and the subsequent enhancement of the GABAergic signaling) were observed in neuropathic pain animal models and were interpreted as a therapeutic strategy rescuing deficient GABAergic neurotransmission. This evidence concerns the gene GAD1 and neuropathic pain.